Article PDF
References
Foulds WS, McCuish A, Barrie T, Green F, Scobie IN, Ghafour IM, et al. Diabetic retinopathy in the West of Scotland: its detection and prevalence, and the cost effectiveness of a proposed screening programme. Health Bull (Edinb) 1983;41:318–26.
Amos AF, McCarty DJ, Zimmet P . The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14(Suppl 5):S1–85.
Rhatigan MC, Leese GP, Ellis J, Ellingford A, Morris AD, Newton RW, Roxburgh STD . Blindness in patients with diabetes who have been screened for eye disease. Eye 1999;13:166–9.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report. Diabetes Care 1997;17:326–38.
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998;317:703–13.
UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713–20.
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755–62.
Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DR, et al. for the United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus. UKPDS 23. BMJ 1998;316:823–8.
The DCCT Research Group. The effect of intensive treatment on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.
Hypertension in Diabetes Study Group. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. HDS 1. J Hypertens 1993;11:309–17.
UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes. UKPDS 40. BMJ 1998;317:720–6.
Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthew DR, et al. Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. UKPDS 30. Arch Ophthalmol 1998;116:297–303.
Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS report 1. Arch Ophthalmol 1985;103:1796–806.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Silvestri, G. Management of retinopathy in type 2 diabetes. Eye 13, 131–132 (1999). https://doi.org/10.1038/eye.1999.38
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.38